Company / Depreciation & Amortization
PULSE BIOSCIENCES, INC. Depreciation & Amortization History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$690.0K
FY2023
5-year range
$690.0K / $690.0K
FY2019-FY2023
Trend
-
vs FY2022
Sector context
#141 of 141
Health Care
What the data says
Among 141 Health Care companies, PULSE BIOSCIENCES, INC. is in the top 0% for depreciation & amortization. Depreciation & Amortization returned to growth in FY2023 after 2 years of decline, reaching $690,000.
Based on SEC 10-K filings.
$690,000 in FY2023 with a 5-year CAGR of +1.4%.
Increased from $494,000 to $690,000 over the past 4 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +17.1%
- 5-Year CAGR
- +1.4%
- 10-Year CAGR
- -
Sector benchmark
Top 0% in Health CareTop 0% of 141This company $690.0K Sector average $344.6M
▼
-99.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +1.4%, indicating consistent growth.
- Ranks #141 out of 141 companies in the Health Care sector.
- Lowest depreciation & amortization in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $690.0K | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $430.0K | -13.0% |
| FY2019 | $494.0K | -23.4% |
| FY2018 | $645.0K | +92.0% |
| FY2017 | $336.0K | +257.4% |
| FY2016 | $94.0K | +84.3% |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026